| 1 |
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?
|
3. They enhance sensitivity and surface area for detection |
|
Nano technology particles are smaller therefore have more surface area, and are also more reactive, making them more sensitive to changes
|
Nanotechnology-enhanced electrochemical sensors offer numerous advantages including improved sensitivity and specificity, the potential for miniaturization, and the capability for real-time monitoring
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?
|
1. Zinc oxide |
|
Gold is a metal, which metals have a high conductivity. Electron transfer is the flow of electricity, meaning that gold particles can facilitate the conduction.
|
Metallic Nanoparticles: Gold, silver, and platinum nanoparticles enhance the electron transfer rates and provide active sites for biomolecule attachment, improving the sensor's performance for detecting glucose, cholesterol, and other analytes.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?
|
3. They improve electron transfer and mechanical strength |
|
Some forms of carbon are good electrical conductors and have stable structures
|
low concentrations of biological markers and environmental pollutants.
Nanotubes, particularly carbon nanotubes (CNTs), are cylindrical
nanostructures with exceptional electrical, mechanical, and thermal
properties [49]. They come in two main forms: single-walled carbon
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs).
The SWCNTs have a single layer of graphene rolled into a tube and
exhibit excellent electrical conductivity and high surface area, making
them suitable for detecting various analytes, including DNA, proteins,
and gases.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?
|
3. Issues in reproducibility and standardization |
|
Nano materials are quite new and industries haven't made standards for them. And nano particles are very sensitive to reactions, which means they need a very specific environment to be produced in
|
hibit unique behaviors and interactions that
are not well understood. The lack of standardized protocols for the
characterization, testing, and evaluation of nanomaterials presents a
significant challenge
and purifying
nanomaterials without compromising their quality is necessary to make
these sensors economically viable for widespread use.
Reproducibility Issues: Variability in the synthesis of gold nanoparticles has led to
inconsistent sensor performance in glucose monitoring devices, necessitating
stringent quality control measures.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?
|
1. Optical diffraction |
|
Quantum dots have unique optical properties that amplify the sensitivity of the sensor
|
Nanotechnology
enables various signal amplification strategies that enhance sensitivity.
Techniques such as the use of nanocatalysts and nanostructured electrodes
amplify the electrochemical signals generated during the detection
process. Quantum dots have been utilized in electrochemical
sensors for the detection of cancer biomarkers. Their unique optical and
electronic properties allow for significant signal amplification,
improving the sensor's sensitivity
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?
|
2. To prevent rejection or toxicity in biological systems |
|
If materials are not biologically compatible with humans or any organism, there’s a chance the body will see it as a foreign object and reject it. Or worse, the material can be toxic
|
Ensuring the biocompatibility
of nanomaterials is crucial for in vivo applications. Some nanomaterials
may induce cytotoxicity or immune responses, limiting their clinical
utility
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How do label-free electrochemical sensors differ from labeled ones?
|
3. They do not rely on additional reagents or markers |
|
They don’t require labels or markers, so they can detect things directly
|
Plasmonic biosensors, utilizing
SPR, are also of significance, as they detect subtle molecular binding
events in real-time without the need for labels
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one promising application of nanotech-based electrochemical sensors?
|
2. Early detection of disease biomarkers |
|
Nano technology can help make early detection and diagnostics of a disease faster and more accurate due to its sensitivity and portability
|
Nanotechnology-enhanced electrochemical sensors offer numerous
advantages including improved sensitivity and specificity, the potential
for miniaturization, and the capability for real-time monitoring [4].
These attributes are critical for the development of next-generation diagnostic tools that can provide rapid, accurate, and on-site testing. The
ongoing research and development in this field promise to revolutionize
medical diagnostics, offering new solutions for early disease detection,
continuous health monitoring, and personalized medicine.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which of the following factors most directly affects the sensor's detection limit?
|
1. Sample pH |
|
Ph levels can majorly affect the results the sensors provide as they are very reactive
|
Nanomaterials can be highly sensitive to changes in temperature,
pH, and other environmental factors, which may lead to false readings or
inconsistent results
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is one of the primary goals of using digital sensing technologies in cancer care?
|
3. Enable earlier and more personalized diagnosis |
|
Better technology can provide more early and accurate detection of cancer, which will make it easier for doctors to treat.
|
The title: Digital sensing technologies in cancer care: A new era in early detection
and personalized diagnosis
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which type of sensor is often used to monitor physical activity in cancer patients?
|
3. Accelerometers |
|
An accelerometer measures the acceleration of an object, which means it can measure the movements of an individual, which usually is physical activity
|
a critical role in monitoring patients during treatment or post-
surgery. One example is a study conducted by Panda et al., which utilizes
smartphone accelerometers to track post-surgical recovery among
cancer patients, offering a more personalized and objective measure of
physical activity
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why are patient-reported outcomes important in digital cancer care systems?
|
3. They provide subjective data complementing sensor metrics |
|
Results directly from the patient can improve the experience of the treatment and the sensors
|
Cancer care and treatment is ultimately for the comfort of the patient and the treatment of the cancer. The patients inputs can help improve future sensors and experience
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is one major advantage of real-time digital sensing in cancer treatment?
|
3. Rapid detection of deterioration in patient condition |
|
If a patients condition changes, the sensors can immediately detect it before doctors can and treatment or adjustments can be adjusted accordingly
|
Integrating wearable sensors
with AI-supported applications could significantly enhance real-time
monitoring. These technologies can analyze physiological data continuously
and send timely alerts to clinicians for improving cancer management
and treatment. Thus, wearable sensors enable proactive,
AI-driven healthcare via the analyses of bodily fluids, e.g., tear, saliva
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?
|
3. Limited digital literacy among patients and providers |
|
Doctors or patients may not know how to use these devices because it is so new especially with the use of ai
|
New technology can take time to be implemented into actual use as it requires a lot of regulations and standardization. New technology can also be challenging to use in real cases
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which stakeholders are considered central to the adoption of digital cancer care platforms?
|
2. Patients and healthcare providers |
|
Healthcare providers and the patients are ultimately the people who are going to use the devices, so it is up to them if they want to adapt it not
|
These new devices and technology can’t be used if the healthcare provider doesn’t spruce of it, or if the patient is uncomfortable using said devices
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Digital sensing systems collect which combination of data types for cancer care optimization?
|
2. Sensor metrics and patient-reported outcomes |
|
Optimizing cancer care requires input from the patient and also the metrics of the sensors
|
Sensor metrics can show how accurate the sensors are and is importantly to optimizing the care
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do digital sensors contribute to improving the quality of life in cancer patients?
|
3. By enabling symptom tracking and early intervention |
|
These devices can help detect symptoms earlier, and unitive the quality of life of the patients as they will get the earliest intervention of these symptoms possible
|
Tracking symptoms can show the doctors how well the patient is doing while going through treatment and afterwards
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What does the article suggest about the future direction of digital sensing in cancer care?
|
3. It holds promise for widespread personalized care |
|
They are hopeful that these sensors can be implemented into the future of cancer care
|
With continued innovation and efforts to overcome existing
challenges outlined in this review, these technologies are poised to
become an integral part of cancer diagnosis and treatment, potentially
transforming oncology practices and enhancing patient outcomes
worldwide.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?
|
1. Using a transducer made of non-conductive materials |
|
A transducer need to be made of a conductive material
|
The transducer needs the information from the electrons to provide an electrical signal that is usable
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?
|
3. A portable chip-based sensor detects protein biomarkers from a blood sample within minutes |
|
The portable chip is one of the emerging technologies that is much more efficient at detecting changes
|
The other choices are traditional ways these tests are performed
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|